A method for determining a vertical position of a horizontally extending interface between first and second components is presented. The first and second components are contained in a laboratory sample container in layers vertically separated from each other. The method comprises generating first data, generating second data in the form of picture data of the laboratory sample container containing the first and second components, determining a first probability distribution function in response to the first data, determining a second probability distribution function in response to the second data, and determining the vertical position of the horizontally extending interface depending on the first and second probability distribution functions. The first data depend on the vertical position of the horizontally extending interface. The first and second probability distribution functions assign a probability of the presence of the horizontally extending interface to a vertical position.

Described herein are devices and methods for rotating a container (e.g., a capped tube containing a sample). The disclosure provides devices and methods of rotating a container using one motor, resulting in a less complex device. The device moves and rotates a container rotating member which in turn is used to rotate a container. The devices can be used in automated analytical instruments (e.g., automated blood analyzers) that automatically transport and detect the identity of sample containers. The devices can also be used in instruments that automatically spin sample containers to mix or homogenize the sample.

Data relating to a particle classified by a centrifugal field flow fractionation device in a preset analysis condition is processed by a data processing apparatus. Inputs of an arbitrary particle diameter and an arbitrary analysis condition are received (Step S101). An elution time of a particle having the particle diameter is calculated based on the input particle diameter and analysis condition (Step S102). The calculated elution time is displayed on a display unit (Step S103).

Devices and methods are described for measuring formed blood component sedimentation rate. Some of the methods may use (1) centrifugal techniques for separating red blood cells from plasma and (2) video and/or still imaging capability. Both may be used alone or in combination to accelerate formed blood component sedimentation and to measure its rate. In one example, the method may advantageously enable rapid measurement of sedimentation rate using small blood sample volumes. Automated image analysis can be used to determine both sedimentation rate and hematocrit. Automated techniques may be used to compensate for effects of hematocrit on uncorrected sedimentation rate data.

A rotor system comprises a rotor constructed and arranged to rotate about an axis of rotation. A source of electromagnetic radiation is positioned at a first position of the rotor, the source of electromagnetic radiation configured to emit electromagnetic radiation at one or more wavelengths. The rotor system further includes a sample region. A detector is positioned at a second position of the rotor, the detector constructed and arranged to receive electromagnetic radiation that traverses at least a portion of the sample region.

A method for collecting plasma includes determining the weight and hematocrit of a donor, and inserting a venous-access device into the donor. The method then withdraws blood from the donor through a draw line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate (1) a percentage of anticoagulant in the collected plasma component, and (2) a volume of pure plasma collected within the plasma collection container. The volume of pure plasma may be based, at least in part, on the calculated percentage of anticoagulant. The method may continue until a target volume of pure plasma is collected within the plasma collection container.

An apparatus for determining the mean corpuscular haemoglobin concentration (MCHC) in a whole blood sample, comprising: a sample holder including an elongate sample chamber having an open end and a closed end; a holding member adapted to receive and retain the sample holder, wherein the holding member may rotate about an axis of rotation, and wherein, when the sample holder is received and retained by the holding member the sample chamber is substantially perpendicular to the axis of rotation; first and second light sources positioned on one side of the sample holder, configured to emit light in respective different frequencies; and at least one light sensor positioned on a second side of the sample holder, opposite from the first side, so that light from the light source may pass through the sample chamber, in at least one rotational position of the sample holder, and impinge on the at least one light sensor.

A method for dynamically evaluating sag of a fluid by providing a test volume of the fluid into an angled sample chamber, wherein the angled sample chamber has a central axis, and wherein the central axis of the angled sample chamber is angled relative to horizontal, rotating the sample chamber about the central axis for a test period, and determining a sag density, wherein the sag density is a density of a fluid sample taken at a sample location within a stratum of the test volume of the fluid present in the angled sample chamber.

A method for collecting plasma includes determining the weight and hematocrit of a donor, and inserting a venous-access device into the donor. The method then withdraws blood from the donor through a draw line connected to a blood component separation device, and introduces anticoagulant into the withdrawn blood. The blood component separation device separates the blood into a plasma component and a second blood component, and the plasma component is collected from the blood component separation device and into a plasma collection container. The method may then calculate (1) a percentage of anticoagulant in the collected plasma component, and (2) a volume of pure plasma collected within the plasma collection container. The volume of pure plasma may be based, at least in part, on the calculated percentage of anticoagulant. The method may continue until a target volume of pure plasma is collected within the plasma collection container.

A method of testing a biological sample, the method comprising: providing a centrifuge sample holder having a camera; arranging a transparent container comprising a fluid test medium in a recess of said centrifuge sample holder, wherein the camera is arranged to image a portion of the container comprising said fluid test medium; arranging said biological sample above and not in contact with said fluid test medium in said container; and with the camera, imaging a mixing of said biological sample with said fluid test medium while centrifuging the sample holder.